Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21518
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLamanna, Anthony-
dc.contributor.authorMaingard, Julian-
dc.contributor.authorTai, James-
dc.contributor.authorRanatunga, Dinesh G-
dc.contributor.authorGoodwin, Mark D-
dc.date2019-06-27-
dc.date.accessioned2019-08-12T05:01:11Z-
dc.date.available2019-08-12T05:01:11Z-
dc.date.issued2019-12-
dc.identifier.citationDiagnostic and interventional imaging 2019; 100(12): 793-800-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/21518-
dc.description.abstractTo report the technical success, complications and long-term outcomes of patients with intrahepatic cholelithiasis not amenable to endoscopic retrograde cholangiopancreatography (ERCP) who were treated with percutaneous transhepatic biliary Laser lithotripsy (PTBLL). A retrospective review of 12 patients who underwent PTBLL for intrahepatic cholelithiasis was performed. There were 5 men and 7 women with a mean age of 46±18 (SD) years (range: 23-75 years). PTBLL was performed when stone clearance using ERCP had previously failed or was not appropriate due to unfavourable anatomy or the presence of multiple stones or a large stone. Percutaneous biliary access into intrahepatic ducts was obtained if not already present and lithotripsy was performed using a HolmiumYAG 2100nM Laser. Patients files were analyzed to determine the technical success, complications and long-term outcomes. Eleven patients (11/12; 92%) had a history of previous hepatobiliary surgery and nine (9/12; 75%) had multiple stones confirmed on preprocedure imaging. A 100% success rate in fragmenting the target stone(s) was achieved and 11/12 patients (92%) had successful first pass extraction of target stone fragments. Two patients (2/12; 17%) required repeat lithotripsy. One patient (1/12; 8%) experienced a major complication in the form of cholangitis. Of patients with long-term follow-up, 4/10 (40%) had recurrence of intrahepatic calculi with a mean time interval of 31 months (range 3-84 months). For patients with intrahepatic biliary calculi not amenable to ERCP, PTBLL provides an effective and safe alternate treatment.-
dc.language.isoeng-
dc.subjectBiliary calculi-
dc.subjectHepatolithiasis-
dc.subjectHolmium Laser-
dc.subjectPercutaneous transhepatic biliary lithotripsy-
dc.titlePercutaneous transhepatic Laser lithotripsy for intrahepatic cholelithiasis.-
dc.typeJournal Article-
dc.identifier.journaltitleDiagnostic and interventional imaging-
dc.identifier.affiliationDepartment of Imaging, Monash Health, Monash, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationInterventional Radiology Service, Department of Radiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Medicine, Deakin University, Waurn Ponds, Australiaen
dc.identifier.doi10.1016/j.diii.2019.05.007-
dc.identifier.orcid0000-0003-0705-2252-
dc.identifier.orcid0000-0001-8958-2411-
dc.identifier.orcid0000-0002-8461-3933-
dc.identifier.pubmedid31257113-
dc.type.austinJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Jun 22, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.